Author(s): Vadivelan Ramachandran, Kirankumar Rapindra Hosalli, Inbakumar Vijayakumar, Lalithkumar Mani, Ruchi Tiwari, Gaurav Tiwari

Email(s): vadivelanr@jssuni.edu.in

DOI: 10.52711/0974-360X.2022.00906   

Address: Vadivelan Ramachandran*, Kirankumar Rapindra Hosalli, Inbakumar Vijayakumar, Lalithkumar Mani, Ruchi Tiwari, Gaurav Tiwari
JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, Nilgiris, Tamil Nadu, India.
*Corresponding Author

Published In:   Volume - 15,      Issue - 11,     Year - 2022


ABSTRACT:
Cancer can be described as the abnormal cell division which is uncontrolled and involves the destruction of neighbour cells and tissues. This condition is significantly holds up a fact that 18 million fresh cases were detected during 2018 and the prevalence rate of cancer within 0 to 74 years is 20.2%. WHO stated that 9.6 million deaths worldwide occur by this disease. A complete cure for cancer has not been found yet but in recent years researches are made in the development of site-specific drugs with low cytotoxic effect with high specificity. However, amygdalin which belongs to the nitroside group has a standout feature for the presence of cyanide in it, this cyanide involves in the decomposition of carcinogenic substances and ultimately leads to the blocking of the nutrient source to the tumor cells which inhibits further growth of cancer cells leading to the cancer cell apoptosis. Amygdalin is extensively used in various diseases such as bronchitis, nausea, leprosy, asthma, etc but recently the antitumor property was evident in a large number of in-vitro studies in various types of cancer such as breast, renal, bladder, cervical, prostate by inhibiting the growth of tumor cells, apoptosis, and reducing metastasis of tumor cells. During this review, we look upon the role of amygdalin in a range of diseases and mainly focused on the treatment of various types of cancers.


Cite this article:
Vadivelan Ramachandran, Kirankumar Rapindra Hosalli, Inbakumar Vijayakumar, Lalithkumar Mani, Ruchi Tiwari, Gaurav Tiwari. A review on antitumor action of amygdalin on various types of cancers. Research Journal of Pharmacy and Technology.2022; 15(11):5373-0. doi: 10.52711/0974-360X.2022.00906

Cite(Electronic):
Vadivelan Ramachandran, Kirankumar Rapindra Hosalli, Inbakumar Vijayakumar, Lalithkumar Mani, Ruchi Tiwari, Gaurav Tiwari. A review on antitumor action of amygdalin on various types of cancers. Research Journal of Pharmacy and Technology.2022; 15(11):5373-0. doi: 10.52711/0974-360X.2022.00906   Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-11-91


REFERENCES:
1.    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA: A Cancer Journal for Clinicians. 2020;70(1):7–30. doi:10.3322/caac.21601
2.    Soni A, Femida P, Sharma P. In-vitro cytotoxic activity of plant saponin extracts on breast cancer cell-line. Rese Jour of Pharmac and Phytoch. 2017;9(1): 17.doi:10.5958/0975-4385.2017.00003.6.
3.    Praveena CH, Pramod K, Ajithkumar KC. Dendritic cell vaccine for cancer therapy. Rese Jour Pharmacol and Pharmacod.      2016;8(3): 141.doi:10.5958/2329-5836.2016.00026.4.
4.    Prabha SB, Rao M, Kumar MRR. Evaluation of in vitro Antioxidant, Antibacterial and Anticancer activities of leaf extracts of Cleome rutidosperma. Rese Jour of Pharm and Technol. 2017;10(8): 2492.doi: 10.5958/0974-360X.2017.00440.1
5.    Liczbiński P, Bukowska B. Molecular mechanism of amygdalin action in vitro: review of the latest research. Immunopharmacol Immunotoxicol. 2018 Jun;40(3):212–8. doi:10.1080/08923973.2018.1441301.
6.    Savic IM, Nikolic VD, Savic-Gajic IM, Nikolic LB, Ibric SR, Gajic DG. Optimization of technological procedure for amygdalin isolation from plum seeds (Pruni domesticae semen). Front Plant Sci [Internet]. 2015 [cited 2021 Jan 29];6. Available from: https://www.frontiersin.org/articles/10.3389/fpls.2015.00276/full.  doi:10.3389/fpls.2015.00276.
7.    Jaszczak-Wilke E, Polkowska Ż, Koprowski M, Owsianik K, Mitchell AE, Bałczewski P. Amygdalin: Toxicity, Anticancer Activity and Analytical Procedures for Its Determination in Plant Seeds. Molecules. 2021 Jan;26(8):2253. doi:10.3389/fpls.2015.00276.
8.    Song Z, Xu X. Advanced research on anti-tumor effects of amygdalin. Journal of cancer research and therapeutics. 2014 Aug 1;10:C3–7. doi: 10.4103/0973-1482.139743.
9.    Suchard JR, Wallace KL, Gerkin RD. Acute cyanide toxicity caused by apricot kernel ingestion. Ann Emerg Med. 1998 Dec;32(6):742–4. doi:10.1016/S0196-0644(98)70077-0.
10.    Chang H-K, Shin M-S, Yang H-Y, Lee J-W, Kim Y-S, Lee M-H, et al. Amygdalin induces apoptosis through regulation of Bax and Bcl-2 expressions in human DU145 and LNCaP prostate cancer cells. Biol Pharm Bull. 2006 Aug;29(8):1597–602.  doi:10.1248/bpb.29.1597.
11.    Ioannis P, Anastasis S, Andreas Y. Tripterygium Wilfordii Extract (Triptolide) and Amygdalin Promotes Cell death in Cancer Cells: True or a Myth. AJCP. 2015 Sep 5;3(4):77–83. doi:10.12691.
12.    He X-Y, Wu L-J, Wang W-X, Xie P-J, Chen Y-H, Wang F. Amygdalin - A pharmacological and toxicological review. J Ethnopharmacol. 2020 May 23; 254:112717. do: 10.1016/j.jep.2020.112717.
13.    Chandrasekar R, Sivagami B, Babu MN. A Pharmacoeconomic Focus on Medicinal Plants with Anticancer Activity. Rese Jour of Pharmac and Phytoch. 2018;10(1):91. doi:10.5958/0975-4385.2018.00015.8.
14.    Park H-J, Yoon S-H, Han L-S, Zheng L-T, Jung K-H, Uhm Y-K, et al. Amygdalin inhibits genes related to cell cycle in SNU-C4 human colon cancer cells. World J Gastroenterol. 2005 Sep 7;11(33):5156–61. doi: 10.3748/wjg. v11.i33.5156.
15.    Perez JJ. Amygdalin analogs for the treatment of psoriasis. Future Med Chem. 2013 May;5(7):799–808. doi:10.4155/fmc.13.27
16.    Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008 Jan;214(2):199–210. doi:10.1002/path.2277.
17.    Boor P, Ostendorf T, Floege J. Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol. 2010 Nov;6(11):643–56. doi:10.1038/nrneph.2010.120.
18.    Guo J, Wu W, Sheng M, Yang S, Tan J. Amygdalin inhibits renal fibrosis in chronic kidney disease. Mol Med Rep. 2013 May;7(5):1453–7. doi:10.3892/mmr.2013.1391.
19.    Chen L, Li L, Chen J, Li L, Zheng Z, Ren J, et al. Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells. Oncotarget. 2015 Dec 15;6(40):42530–40. doi: 10.18632/oncotarget.6466.
20.    Wang R, Zhang D, Tang D, Sun K, Peng J, Zhu W, et al. Amygdalin inhibits TGFβ1-induced activation of hepatic stellate cells (HSCs) in vitro and CCl4-induced hepatic fibrosis in rats in vivo. International Immunopharmacology. 2021 Jan 1; 90:107151. doi: 10.1016/j.intimp.2020.107151.
21.    Kisseleva T, Brenner DA. Anti-fibrogenic Strategies and the regression of fibrosis. Best Pract Res Clin Gastroenterol. 2011 Apr;25(2):305–17. doi: 10.1016/j.bpg.2011.02.011.
22.    Yahfoufi N, Alsadi N, Jambi M, Matar C. The immunomodulatory and anti-inflammatory role of polyphenols. Nutrients. 2018 Nov;10(11):1618. doi:10.3390/nu10111618
23.    Boshtam M, Asgary S, Kouhpayeh S, Shariati L, Khanahmad H. Aptamers Against Pro- and Anti-Inflammatory Cytokines: A      Review. Inflammation. 2017 Feb;40(1):340–9. doi:10.1007/s10753-016-0477-1.
24.    Zhang A, Pan W, Lv J, Wu H. Protective Effect of Amygdalin on LPS-Induced Acute Lung Injury by Inhibiting NF-κB and NLRP3        Signaling Pathways. Inflammation. 2017 Jun;40(3):745–51.doi:10.1007/s10753-017-0518-4.
25.    Adewusi SRA, Oke OL. On the metabolism of amygdalin. 1. The LD50 and biochemical changes in rats. Canadian Journal of Physiology and Pharmacology [Internet]. 2011 Feb 13 [cited 2021 Feb 11]; Available from: https://cdnsciencepub.com. doi:10.1139/y85-177.
26.    Rauws AG, Olling M, Timmerman A. The pharmacokinetics of prunasin, a metabolite of amygdalin. J Toxicol Clin Toxicol. 1982 Oct;19(8):851–6. doi:10.3109/15563658208992518.
27.    Carter JH, McLafferty MA, Goldman P. Role of the gastrointestinal microflora in amygdalin (laetrile)-induced cyanide toxicity. Biochemical Pharmacology. 1980 Feb 1;29(3):301–4. doi:10.1016/0006-2952(80)90504-3.
28.    Blaheta RA, Nelson K, Haferkamp A, Juengel E. Amygdalin, quackery or cure?. Phytomedicine. 2016 Apr 15;23(4):367-76. doi:10.1016/j.phymed.2016.02.004
29.    Rauws AG, Olling M, Timmerman A. The pharmacokinetics of amygdalin. Archives of toxicology. 1982 Mar 1;49(3-4):311-9.doi: 10.1007/bf00347879.
30.    Gottlieb AB. Psoriasis: emerging therapeutic strategies. Nature reviews Drug discovery. 2005 Jan;4(1):19-34.doi:10.1038/nrd1607.
31.    Milazzo S, Horneber M. Laetrile treatment for cancer. Cochrane Database Syst Rev. 2015 Apr 28;(4). doi :10.1002/14651858.
32.    Wyllie AH, Kerr JR, Currie AR. Cell death: the significance of apoptosis. International review of cytology. 1980 Jan 1; 68:251-306. doi:10.1016/S0074-7696(08)62312-8
33.    Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell. 1994 Aug 26;78(4):539–42.doi: 10.1016/0092-8674(94)90518-5
34.    Kulchenko NG, Kostin AA, Chibisov SM, Eremina IZ, Tolkachev AO, Syatkin SP, et al. Modern Principles of Early Diagnosis of Prostate Cancer. Rese Jour of Pharm and Technol. 2017;10(3):696. doi: 10.5958/0974-360X.2017.00130.5
35.    Dange VN, Shid SJ, Magdum CS, Mohite SK. A Review on Breast cancer: An Overview. Asian Jour Pharmac Rese. 2017;7(1): 49-51.doi: 10.5958/2231-5691.2017.00008.9.
36.    Lee HM, Moon A. Amygdalin Regulates Apoptosis and Adhesion in Hs578T Triple-Negative Breast Cancer Cells. Biomol Ther (Seoul). 2016 Jan;24(1):62–6. doi: 10.4062/biomolther.2015.172
37.    Fernald K, Kurokawa M. Evading apoptosis in cancer. Trends Cell Biol. 2013 Dec;23(12):620–33.doi: 10.1016/j.tcb.2013.07.006
38.    Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 1994 Sep;371(6495):346-7.doi:10.1038/371346a0
39.    Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 1995 Nov 24;270(5240): 1326-31.doi: 10.1126/science.270.5240.1326
40.    Salama R, Ramadan A, Alsanory T, Herdan M, Fathallah O, Alsanory A. Experimental and therapeutic trials of amygdalin. Int J Biochem Pharmacol. 2019 Oct 28;1(1):21-6. doi: 10.18689/ijbp-1000105
41.    Moon J-Y, Kim S-W, Yun G-M, Lee H-S, Kim Y-D, Jeong G-J, et al. Inhibition of cell growth and down-regulation of telomerase activity by amygdalin in human cancer cell lines. Animal Cells and Systems. 2015 Sep 3;19(5):295–304. doi:10.1080/19768354.2015.1060261
42.    Vu M, Yu J, Awolude OA, Chuang L. Cervical cancer worldwide. Current problems in cancer. 2018 Sep 1;42(5):457-65. doi:10.1016/j.currproblcancer.2018.06.003
43.    Vijay A, Sona VP, Radha A, Moorthi PV. A Review on Advancement Perspectives in Cervical Cancer. Research Journal of Pharmacy and Technology. 2017 Dec 30;10(12):4410–4. doi: 10.5958/0974-360X.2017.00813.7
44.    Chen Y, Ma J, Wang F, Hu J, Cui A, Wei C, Yang Q, Li F. Amygdalin induces apoptosis in human cervical cancer cell line HeLa cells. Immunopharmacology and immunotoxicology. 2013 Feb 1;35(1): 43-51.doi:10.3109/08923973.2012.738688
45.    Makarević J, Tsaur I, Juengel E, Borgmann H, Nelson K, Thomas C, et al. Amygdalin delays cell cycle progression and blocks growth of prostate cancer cells in vitro. Life Sci. 2016 Feb 15; 147:137–42.doi: 10.1016/j.lfs.2016.01.039
46.    Park J-H, Seo B-I, Cho S-Y, Park K-R, Choi S-H, Han C-K, et al. Single Oral Dose Toxicity Study of Prebrewed Armeniacae Semen in Rats. Toxicol Res. 2013 Jun;29(2):91–8.doi:10.5487/TR.2013.29.2.091
47.    Makarević J, Rutz J, Juengel E, Kaulfuss S, Reiter M, Tsaur I, Bartsch G, Haferkamp A, Blaheta RA. Amygdalin blocks bladder cancer cell growth in vitro by diminishing cyclin A and cdk2. PloS one. 2014 Aug 19;9(8): e105590.doi: 10.1371/journal.pone.0105590
48.    Makarević J, Rutz J, Juengel E, Kaulfuss S, Tsaur I, Nelson K, Pfitzenmaier J, Haferkamp A, Blaheta RA. Amygdalin influences bladder cancer cell adhesion and invasion in vitro. PloS one. 2014 Oct 15;9(10): e110244.doi: 10.1371/journal.pone.0110244
49.    Gogolin S, Ehemann V, Becker G, Brueckner LM, Dreidax D, Bannert S, Nolte I, Savelyeva L, Bell E, Westermann F. CDK4 inhibition restores G₁-S arrest in MYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage. Cell cycle. 2013 Apr 1;12(7): 1091-104.doi:10.4161/cc.24091
50.    Haque I, Subramanian A, Huang CH, Godwin AK, Van Veldhuizen PJ, Banerjee S, Banerjee SK. The role of compounds derived from natural supplement as anticancer agents in renal cell carcinoma: a review. International journal of molecular sciences. 2018 Jan;19(1):107.doi:10.3390/ijms19010107.
51.    Stock CC, Martin DS, Sugiura K, Fugmann RA, Mountain IM, Stockert E, et al. Antitumor tests of amygdalin in spontaneous animal tumor systems. J Surg Oncol. 1978;10(2):89–123.doi:10.1002/jso.2930100203
52.    Shi J, Chen Q, Xu M, Xia Q, Zheng T, Teng J, et al. Recent updates and future perspectives about amygdalin as a potential anticancer agent: A review. Cancer Med. 2019 Jun;8(6):3004–11.doi:10.1002/cam4.2197
53.    Li Y-L, Li Q-X, Liu R-J, Shen X-Q. Chinese Medicine Amygdalin and β-Glucosidase Combined with Antibody Enzymatic Prodrug System As A Feasible Antitumor Therapy. Chin J Integr Med. 2018 Mar;24(3):237–40.doi:10.1007/s11655-015-2154-x
54.    Syrigos KN, Rowlinson-Busza G, Epenetos AA. In vitro cytotoxicity following specific activation of amygdalin by beta-glucosidase conjugated to a bladder cancer-associated monoclonal antibody. Int J Cancer. 1998 Dec 9;78(6):712–9. doi.org/10.1002/(SICI)1097-0215(19981209)78:6<712: AID-IJC8>3.0.CO;2-D
55.    Wang Y, Dong D, Jiang S, Zhang E, Zheng W, Mao L, et al. miR-216b Post-Transcriptionally Downregulates Oncogene KRAS and Inhibits Cell Proliferation and Invasion in Clear Cell Renal Cell Carcinoma. CPB. 2018;49(5):1755–65.doi:10.1159/000493621
56.    Bai J, Duan J, Liu R, Du Y, Luo Q, Cui Y, et al. Engineered targeting tLyp-1 exosomes as gene therapy vectors for efficient delivery of siRNA into lung cancer cells. Asian Journal of Pharmaceutical Sciences. 2020 Jul 1;15(4):461–71.doi: 10.1016/j.ajps.2019.04.002
57.    Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. InMayo clinic proceedings 2008 May 1 (Vol. 83, No. 5, pp. 584-594). doi:10.4065/83.5.584
58.    Moertel CG, Ames MM, Kovach JS, Moyer TP, Rubin JR, Tinker JH. A pharmacologic and toxicological study of amygdalin. JAMA. 1981 Feb 13;245(6):591–4. doi:10.1001/jama.1981.03310310033018
59.    Shim S-M, Kwon H. Metabolites of amygdalin under simulated human digestive fluids. Int J Food Sci Nutr. 2010 Dec;61(8):770–9.doi:10.3109/09637481003796314.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available